Trial Profile
A retrospective study of Ustekinumab in pediatric Crohn disease patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jan 2018
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Crohn's disease
- Focus Adverse reactions; Therapeutic Use
- 08 Jan 2018 New trial record